Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 36,710 |
|
|||||
| News | (2) | ||||||
| Day High | 9.46 | Low High |
|||||
| Day Low | 9.20 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Nyxoah SA | NYXH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.24 | 2.62% | 9.41 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.20 | 9.20 | 9.46 | 9.41 | 9.17 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 229 | 36,710 | $ 9.34 | $ 342,738 | - | 4.00 - 20.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:03 | 1 | $ 9.38 | USD |
Nyxoah SA Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 269.12M | 28.66M | - | 4.35M | -43.21M | -1.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Nyxoah News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NYXH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.50 | 9.46 | 8.17 | 8.81 | 150,814 | 0.91 | 10.71% |
| 1 Month | 10.15 | 12.21 | 7.29 | 8.92 | 65,002 | -0.74 | -7.29% |
| 3 Months | 14.69 | 20.00 | 7.29 | 11.81 | 52,467 | -5.28 | -35.94% |
| 6 Months | 5.05 | 20.00 | 4.00 | 10.55 | 49,198 | 4.36 | 86.34% |
| 1 Year | 7.60 | 20.00 | 4.00 | 10.13 | 27,167 | 1.81 | 23.82% |
| 3 Years | 30.02 | 37.00 | 4.00 | 11.58 | 18,518 | -20.61 | -68.65% |
| 5 Years | 30.02 | 37.00 | 4.00 | 11.58 | 18,518 | -20.61 | -68.65% |
Nyxoah Description
| Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke. |
